Variables | HR (95%CI) | P |
---|---|---|
Overall survival | ||
rN classification (rN1–2 vs. rN3) | 3.72 (1.24–14.55) | 0.026 |
rENE (without vs. with) | 2.86 (0.75–10.85) | 0.056 |
Regional relapse-free survival | ||
Failure patterns (in-field vs. out-field) | 2.86 (1.02–8.03) | 0.047 |
Bilateral of LN (no vs. yes) | 6.35 (1.65–24.41) | 0.007 |
Chemotherapy at recurrence (without vs. with) | 2.41 (0.92–6.34) | 0.074 |
Distant metastasis-free survival | ||
rENE (without vs. with) | 4.22 (0.88–20.17) | 0.072 |
Number of positive LN (< 6 vs. ≥ 6) | 3.26 (0.91–11.72) | 0.070 |